These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 32597813)

  • 1. Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.
    Solis E; Hascup KN; Hascup ER
    J Alzheimers Dis; 2020; 76(4):1179-1198. PubMed ID: 32597813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
    Bell RD; Zlokovic BV
    Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
    Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
    Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.
    Apátiga-Pérez R; Soto-Rojas LO; Campa-Córdoba BB; Luna-Viramontes NI; Cuevas E; Villanueva-Fierro I; Ontiveros-Torres MA; Bravo-Muñoz M; Flores-Rodríguez P; Garcés-Ramirez L; de la Cruz F; Montiel-Sosa JF; Pacheco-Herrero M; Luna-Muñoz J
    Metab Brain Dis; 2022 Jan; 37(1):39-50. PubMed ID: 34406560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
    Sagare AP; Bell RD; Zlokovic BV
    J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C; Walker L; Rauchmann BS; Perneczky R
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    Parodi-Rullán R; Sone JY; Fossati S
    J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. tPA Deficiency Underlies Neurovascular Coupling Dysfunction by Amyloid-β.
    Park L; Zhou J; Koizumi K; Wang G; Anfray A; Ahn SJ; Seo J; Zhou P; Zhao L; Paul S; Anrather J; Iadecola C
    J Neurosci; 2020 Oct; 40(42):8160-8173. PubMed ID: 32928888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia.
    Tayler H; Miners JS; Güzel Ö; MacLachlan R; Love S
    Brain Pathol; 2021 Jul; 31(4):e12935. PubMed ID: 33410232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives.
    Fisher RA; Miners JS; Love S
    Brain Pathol; 2022 Nov; 32(6):e13061. PubMed ID: 35289012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.
    Sagare AP; Bell RD; Zlokovic BV
    Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
    Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
    Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. tPA supplementation preserves neurovascular and cognitive function in Tg2576 mice.
    Uekawa K; Anfray A; Ahn SJ; Casey N; Seo J; Zhou P; Iadecola C; Park L
    Alzheimers Dement; 2024 Jul; 20(7):4572-4582. PubMed ID: 38899570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.
    Han BH; Zhou ML; Abousaleh F; Brendza RP; Dietrich HH; Koenigsknecht-Talboo J; Cirrito JR; Milner E; Holtzman DM; Zipfel GJ
    J Neurosci; 2008 Dec; 28(50):13542-50. PubMed ID: 19074028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulants for Treatment of Alzheimer's Disease.
    Grossmann K
    J Alzheimers Dis; 2020; 77(4):1373-1382. PubMed ID: 32925057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
    Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease.
    Lloyd GM; Trejo-Lopez JA; Xia Y; McFarland KN; Lincoln SJ; Ertekin-Taner N; Giasson BI; Yachnis AT; Prokop S
    Acta Neuropathol Commun; 2020 Mar; 8(1):31. PubMed ID: 32164763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Neurovascular Unit Dysfunction in Alzheimer's Disease.
    Soto-Rojas LO; Pacheco-Herrero M; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Villegas-Rojas MM; Harrington CR; de la Cruz F; Garcés-Ramírez L; Luna-Muñoz J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
    Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.